Literature DB >> 30852775

Epicardial fat thickness is significantly increased and related to LDL cholesterol level in patients with familial hypercholesterolemia.

Yurdaer Dönmez1, Atilla Bulut2.   

Abstract

PURPOSE: Increased epicardial fat thickness (EFT) is accepted as a risk factfcardiovascular diseases in some studies. There are conflicting results about the relation between plasma low-density lipoprotein cholesterol (LDL-C) level and EFT. As well, the relation between EFT and familial hypercholesterolemia is not clearly documented in the literature. Our aim was to investigate EFT in familial hypercholesterolemia patients and to determine which parameters were related to EFT increase.
METHODS: A total of 150 subjects enrolled in our study. Subjects were separated into two groups: 75 hypercholesterolemia patients (16 men, mean age 52.8 ± 7.4 years) and 75 familial hypercholesterolemia patients (26 men, mean age 50.7 ± 9.2 years). Medical history assessments and complete physical examinations were done. Routine laboratory tests and echocardiographic measurements were performed.
RESULTS: Coronary artery disease frequency was significantly higher in the familial hypercholesterolemia group (p < 0.001). This group had significantly higher TC and LDL-C levels than the hypercholesterolemia group (p < 0.05 for all). EFT values were higher in the familial hypercholesterolemia group, and were significantly different than in the other group (p < 0.001). LDL-C was found to be independently related to EFT in the linear regression analysis.
CONCLUSIONS: Epicardial fat thickness increased in the familial hypercholesterolemia patients. In addition, LDL-C levels were significantly crelated with increased EFT.

Entities:  

Keywords:  Epicardial fat thickness; Familial hypercholesterolemia

Mesh:

Substances:

Year:  2019        PMID: 30852775      PMCID: PMC6704218          DOI: 10.1007/s40477-019-00368-3

Source DB:  PubMed          Journal:  J Ultrasound        ISSN: 1876-7931


  24 in total

1.  Relation between epicardial adipose tissue and left ventricular mass.

Authors:  Gianluca Iacobellis; Maria Cristina Ribaudo; Alessandra Zappaterreno; Concetta Valeria Iannucci; Frida Leonetti
Journal:  Am J Cardiol       Date:  2004-10-15       Impact factor: 2.778

Review 2.  Innate immunity and adipose tissue biology.

Authors:  Andreas Schäffler; Jürgen Schölmerich
Journal:  Trends Immunol       Date:  2010-06       Impact factor: 16.687

3.  Visceral adipose tissue, a potential risk factor for carotid atherosclerosis: results of the Multicultural Community Health Assessment Trial (M-CHAT).

Authors:  Scott A Lear; Karin H Humphries; Simi Kohli; Jiri J Frohlich; C Laird Birmingham; G B John Mancini
Journal:  Stroke       Date:  2007-08-02       Impact factor: 7.914

4.  Mapping epicardial fat with multi-detector computed tomography to facilitate percutaneous transepicardial arrhythmia ablation.

Authors:  Suhny Abbara; Jay C Desai; Ricardo C Cury; Javed Butler; Koen Nieman; Vivek Reddy
Journal:  Eur J Radiol       Date:  2006-01-23       Impact factor: 3.528

Review 5.  Echocardiographic epicardial fat: a review of research and clinical applications.

Authors:  Gianluca Iacobellis; Howard J Willens
Journal:  J Am Soc Echocardiogr       Date:  2009-12       Impact factor: 5.251

6.  Pericardial fat burden on ECG-gated noncontrast CT in asymptomatic patients who subsequently experience adverse cardiovascular events.

Authors:  Victor Y Cheng; Damini Dey; Balaji Tamarappoo; Ryo Nakazato; Heidi Gransar; Romalisa Miranda-Peats; Amit Ramesh; Nathan D Wong; Leslee J Shaw; Piotr J Slomka; Daniel S Berman
Journal:  JACC Cardiovasc Imaging       Date:  2010-04

7.  The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Jingzhong Ding; Fang-Chi Hsu; Tamara B Harris; Yongmei Liu; Stephen B Kritchevsky; Moyses Szklo; Pamela Ouyang; Mark A Espeland; Kurt K Lohman; Michael H Criqui; Matthew Allison; David A Bluemke; J Jeffrey Carr
Journal:  Am J Clin Nutr       Date:  2009-07-01       Impact factor: 7.045

8.  Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study.

Authors:  Guido A Rosito; Joseph M Massaro; Udo Hoffmann; Frederick L Ruberg; Amir A Mahabadi; Ramachandran S Vasan; Christopher J O'Donnell; Caroline S Fox
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

9.  Threshold values of high-risk echocardiographic epicardial fat thickness.

Authors:  Gianluca Iacobellis; Howard J Willens; Giuseppe Barbaro; Arya M Sharma
Journal:  Obesity (Silver Spring)       Date:  2008-02-07       Impact factor: 5.002

10.  Association between non-subcutaneous adiposity and calcified coronary plaque: a substudy of the Multi-Ethnic Study of Atherosclerosis.

Authors:  Jingzhong Ding; Stephen B Kritchevsky; Fang-Chi Hsu; Tamara B Harris; Gregory L Burke; Robert C Detrano; Moyses Szklo; Michael H Criqui; Matthew Allison; Pamela Ouyang; Elizabeth R Brown; J Jeffrey Carr
Journal:  Am J Clin Nutr       Date:  2008-09       Impact factor: 7.045

View more
  3 in total

1.  Profiling of Non-Coding Regulators and Their Targets in Epicardial Fat from Patients with Coronary Artery Disease.

Authors:  Brendin Flinn; Christopher Adams; Nepal Chowdhury; Todd Gress; Nalini Santanam
Journal:  Int J Mol Sci       Date:  2022-05-10       Impact factor: 6.208

Review 2.  Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial Hypercholesterolemia.

Authors:  Eszter Berta; Noémi Zsíros; Miklós Bodor; István Balogh; Hajnalka Lőrincz; György Paragh; Mariann Harangi
Journal:  Genes (Basel)       Date:  2022-06-27       Impact factor: 4.141

3.  Epicardial Adipose Tissue and Cardiovascular Risk Assessment in Ultra-Marathon Runners: A Pilot Study.

Authors:  Michał Konwerski; Marek Postuła; Marzena Barczuk-Falęcka; Anna Czajkowska; Anna Mróz; Katarzyna Witek; Wawrzyniec Bakalarski; Aleksandra Gąsecka; Łukasz A Małek; Tomasz Mazurek
Journal:  Int J Environ Res Public Health       Date:  2021-03-18       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.